Role of ultrasound and contrast-enhanced ultrasound in patients with cerebrovascular disease

European Heart Journal, Supplement

Volumn 4, Issue 3, 2002, Pages

  Deklunder, G ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Carotid artery disease; Contrast media; Transcranial doppler; Ultrasound

Indexed keywords

CONTRAST MEDIUM; FLUOROCARBON; SULFUR HEXAFLUORIDE;

ARTERIOVENOUS MALFORMATION; ARTICLE; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN ATHEROSCLEROSIS; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN SURGERY; CEREBROVASCULAR DISEASE; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; DRUG SAFETY; ECHOENCEPHALOGRAPHY; ENERGY; EVALUATION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; SIDE EFFECT; SIGNAL DETECTION; SIGNAL NOISE RATIO; SKULL; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 0346192175     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(02)90101-X     Document Type: Article

References (29)

1. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy individual patients: a risk-modelling study. Lancet 1999; 353: 2105-10.
2. Bazzocchi M, Quaia E, Zuiani C, Moroldo M. Transcranial doppler: state of the art. Eur J Radiol 1998; 27(suppl 2): S141-8.
3. Deklunder G, Gautier C, Custoza E. Contrast agents and carotid artery stenosis [in French]. Journal d'Echographie et de Medicine par les Ultra sons 1998; 19: 426-30.
4. Kaps M, Schaffer P, Beller KD et al. Transcranial echo contrast studies in healthy volunteers. Stroke 1995; 26: 2048-52.
5. Albrecht T, Urbank A, Mahler M et al. Prolongation and optimization of doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience. Radiology 1998; 207: 339-47.
6. Uggowitzer M, Kugler C, Riccabona M et al. Cerebral arteriovenous malformations: diagnostic value of echo-enhanced transcranial doppler sonography compared with angiography. Am J Neuroradiol 1999; 20: 101-6.
7. Correas JM, Burns PN, Lai X, Qi X. Infusion versus bolus of an ultrasound contrast agent: in vivo dose-response measurements of BR1. Invest Radiol 2000; 35: 72-9.
8. Bokor D. Diagnostic efficacy of SonoVue. Am J Cardiol 2000; 86: 19-24.
9. Kaps M, Seidel G, Bokor D et al. Safety and ultrasound enhancing potentials of a new sulfur hexafluoride-containing agent in the cerebral circulation. J Neuroimaging 1999; 9: 150-4.
10. Campani R, Calliada F, Bottinelli O et al. Contrast enhancing agents in ultrasonography: clinical applications. Eur J Radiol 1988; 27: S161-70.
11. Basseau F, Grenier N, Trillaud H et al. Doppler frequency shift and time-domain velocity enhancement induced by an ultrasonographic contrast agent. J Ultrasound Med 2000; 19: 171-6.
12. Khan HG, Gailloud P, Bude RO et al. The effect of contrast material on transcranial doppler evaluation of normal middle cerebral artery peak systolic velocity. Am J Neuroradiol 2000; 21: 386-90.
13. Gutberlet M, Venz S, Zendel W et al. Do ultrasonic contrast agents artificially increase maximum doppler shift? In vivo study of human common carotid arteries. J Ultrasound Med 1988; 17: 97-102.
14. Melany ML, Grant EG, Farooki S et al. Effect of US contrast agents on spectral velocities: in vitro evaluation. Radiology 1999; 211: 427-31.
15. Droste DW, Jürgens R, Nabavi DG et al. Echocontrast-enhanced ultrasound of extracranial internal carotid artery high-grade stenosis and occlusion. Stroke 1999; 30: 2302-6.
16. Sitzer M, Fürst G, Siebler M, Steinmetz H. Usefulness of an intravenous contrast medium in the characterization of high-grade internal carotid stenosis with color Doppler-assisted duplex imaging. Stroke 1994; 25: 385-9.
17. Otis S, Rush M, Boxajian R. Contrast-enhanced transcranial imaging; results of an american phase-two study. Stroke 1995; 26: 203-9.
18. Furst G, Saleh A, Wenserski F et al. Reliability and validity of noninvasive imaging of internal carotid artery pseudo-occlusion. Stroke 1999; 30: 1444-9.
19. Holden A, Hope JK, Osborne M et al. Value of a contrast agent in equivocal ultrasound studies: pictorial essay. Australas Radiol 2000; 44: 253-60.
20. Gautier C, Deklunder G, Leclerc X et al. Diagnosis management of subocclusive disease of the carotid artery [in French; abstract]. Arch Mal Coeur Vais 2000; 93: 1257A.
21. Haggag K, Russel D, Brucher R et al. Contrast enhanced pulsed doppler and coulor-coded duplex studies of the cranial vasculature. Eur J Neurol 1999; 6: 443-8.
22. Gerriets T, Seidel G, Fiss I, Kaps M. Contrast-enhanced transcranial color-coded duplex sonography: efficiency and validity. Neurology 1999; 52: 1133-7.
23. Droste DW, Jürgens R, Weber S et al. Benefit of echocontrast- enhanced transcranial color-coded duplex ultrasound in the assessment of intracranial collateral pathways. Stroke 2000; 31: 920-3.
24. Griewing B., Motsch L, Piek J et al. Transcranial power mode doppler duplex sonography of intracranial aneurysms. J Neuroimaging 1998; 8: 155-8.
25. Delcker A, Turowski B. Diagnostic value of three-dimensional transcranial contrast duplex sonography. J Neuroimaging 1997; 7: 139-44.
26. Klötzsch C, Bozzato A, Lammers G et al. Three-dimensional transcranial color-coded sonography of cerebral aneurysms. Stroke 1999; 30: 2285-90.
27. Postert T, Muhs A, Meves S et al. Transient response harmonic imaging. An ultrasound technique related to brain perfusion. Stroke 1998; 29: 1901-7.
28. Itoh T, Matsumoto M, Uchimoto R et al. Perfusion imaging of the brain by B-mode ultrasonography. An experimental study in rabbits. Stroke 1995; 26: 2353-7.
29. Puls I, Becker G, Maurer M, Mullges W. Cerebral arteriovenous transit time (CTT): a sonographic assesment of cerebral microcirculation using ultrasound contrast agents. Ultrasound Med Biol 1999; 25: 503-7.